These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8341127)

  • 1. Human immunodeficiency virus and leprosy.
    Lucas S
    Lepr Rev; 1993 Jun; 64(2):97-103. PubMed ID: 8341127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprosy and AIDS: a review of the literature and speculations on the impact of CD4+ lymphocyte depletion on immunity to Mycobacterium leprae.
    Miller RA
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):639-44. PubMed ID: 1687045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term follow up of patients with multibacillary leprosy and HIV infection.
    Jacob M; George S; Pulimood S; Nathan N
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):392-5. PubMed ID: 9030104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does concomitant hiv infection has any epidemiological, clinical, immunopathological and therapeutic relevance in leprosy?
    Kar HK; Sharma P
    Indian J Lepr; 2007; 79(1):45-60. PubMed ID: 17578267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HIV infection on leprosy: a three-year survey in Bamako, Mali.
    Lienhardt C; Kamate B; Jamet P; Tounkara A; Faye OC; Sow SO; Bobin P
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):383-91. PubMed ID: 9030103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 (HIV-1) and Mycobacterium leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort.
    Pereira GA; Stefani MM; Araújo Filho JA; Souza LC; Stefani GP; Martelli CM
    Am J Trop Med Hyg; 2004 Nov; 71(5):679-84. PubMed ID: 15569804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus and leprosy: an update.
    Lockwood DN; Lambert SM
    Dermatol Clin; 2011 Jan; 29(1):125-8. PubMed ID: 21095536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of HIV infection on the clinical spectrum of leprosy in Maiduguri.
    Moses AE; Adelowo KA; Nwankwo EA
    Niger Postgrad Med J; 2001 Jun; 8(2):74-7. PubMed ID: 11487905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 reactions in leprosy, neuritis and steroid therapy: the impact of the human immunodeficiency virus.
    Bwire R; Kawuma HJ
    Trans R Soc Trop Med Hyg; 1994; 88(3):315-6. PubMed ID: 7974675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between leprosy and HIV infection in Tanzania.
    van den Broek J; Chum HJ; Swai R; O'Brien RJ
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):203-10. PubMed ID: 9251592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between HIV infection and leprosy: a paradox.
    Ustianowski AP; Lawn SD; Lockwood DN
    Lancet Infect Dis; 2006 Jun; 6(6):350-60. PubMed ID: 16728321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of HIV infection among leprosy patients in Agra, India: trends and perspective.
    Hussain T; Sinha S; Kulshreshtha KK; Katoch K; Yadav VS; Sengupta U; Katoch VM
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):93-9. PubMed ID: 16830651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotype of skin lymphocytic infiltrate in patients co-infected with Mycobacterium leprae and human immunodeficiency virus: a scenario dependent on CD8+ and/or CD20+ cells.
    Massone C; Talhari C; Talhari S; Brunasso AM; Campbell TM; Curcic P; Cerroni L; Ribeiro-Rodrigues R
    Br J Dermatol; 2011 Aug; 165(2):321-8. PubMed ID: 21574977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan.
    Kashala O; Marlink R; Ilunga M; Diese M; Gormus B; Xu K; Mukeba P; Kasongo K; Essex M
    J Infect Dis; 1994 Feb; 169(2):296-304. PubMed ID: 7906291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral Co-infection and Leprosy Outcomes: A Cohort Study.
    Machado PR; Machado LM; Shibuya M; Rego J; Johnson WD; Glesby MJ
    PLoS Negl Trop Dis; 2015; 9(8):e0003865. PubMed ID: 26267882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus type 1 and naive for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome.
    Trindade MA; Valente NY; Manini MI; Takahashi MD; Anjos CF; Benard G; Naafs B
    J Clin Microbiol; 2006 Dec; 44(12):4616-8. PubMed ID: 17021066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprosy and infection with the human immunodeficiency virus in Uganda; a case-control study.
    Kawuma HJ; Bwire R; Adatu-Engwau F
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):521-6. PubMed ID: 7868948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leprosy Reactions in Patients Coinfected with HIV: Clinical Aspects and Outcomes in Two Comparative Cohorts in the Amazon Region, Brazil.
    Pires CA; Jucá Neto FO; de Albuquerque NC; Macedo GM; Batista Kde N; Xavier MB
    PLoS Negl Trop Dis; 2015; 9(6):e0003818. PubMed ID: 26029928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin.
    Bahia El Idrissi N; Iyer AM; Ramaglia V; Rosa PS; Soares CT; Baas F; Das PK
    PLoS One; 2017; 12(5):e0177815. PubMed ID: 28505186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy and immunity in opportunistic parasitic infections in AIDS.
    Zumla A; Croft SL
    Parasitology; 1992; 105 Suppl():S93-101. PubMed ID: 1308934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.